Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
Kyle T. Helzer(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Paul M. Harari(University of Wisconsin Carbone Cancer Center), Felix Y. Feng(University of Michigan), Hamid Emamekhoo(University of Wisconsin Carbone Cancer Center), Hannah Krause(University of Wisconsin–Madison), Andrew J. Armstrong(Duke University), Martin Sjöström(University of California, San Francisco), Kari B. Wisinski(University of Wisconsin Carbone Cancer Center), Yue Shi(University of Wisconsin–Madison), Matti Annala(Tampere University), David A. Quigley(Universidad Católica de Santa Fe), Himisha Beltran(Dana-Farber Cancer Institute), Mark E. Burkard(University of Wisconsin–Madison), Marina N. Sharifi(University of Wisconsin–Madison), Alexander W. Wyatt(University of British Columbia), Menggang Yu(University of Michigan), Jamie M. Sperger(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Christos E. Kyriakopoulos(Dana-Farber Cancer Institute), Grace C. Blitzer(University of Wisconsin–Madison), Scott M. Dehm(University of Minnesota), M. Bassetti(University of Wisconsin–Madison), N. Sethakorn(University of Wisconsin–Madison), Amy K. Taylor(University of Wisconsin–Madison), Matthew L. Bootsma(University of Wisconsin–Madison), Ruth O’Regan(University of Wisconsin Carbone Cancer Center), David Kosoff(University of Wisconsin–Madison), Jennifer L. Schehr(University of Wisconsin–Madison), Katherine R. Kaufmann(University of Wisconsin–Madison), John M. Floberg(University of Wisconsin–Madison), Nicholas R. Rydzewski(University of Wisconsin–Madison), Steve Reese(Incyte (United States)), Joshua M. Lang(University of Wisconsin–Madison)
Cited by 70
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k